Itero Biopharmaceuticals Obtains $12,750,000 New Financing

  • Feed Type
  • Date
    12/31/2008
  • Company Name
    Itero Biopharmaceuticals
  • Mailing Address
    155 Bovet Road San Mateo, CA 94402
  • Company Description
    Itero Biopharmaceuticals is focused on developing value-added follow-on and novel therapeutic proteins and
    antibodies.
  • Website
    http://www.iterobiopharm.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,750,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Panorama Capital
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.